Znn3bq.jpeg
²é¿´: 1384  |  »Ø¸´: 1

fuanxitan

Ìú³æ (СÓÐÃûÆø)

[½»Á÷] BioTechniques£º2015×îÊÜ»¶Ó­µÄ¼¼ÊõÎÄÕ ÒÑÓÐ1È˲ÎÓë

1. Visual detection of isothermal nucleic acid amplification using pH-sensitive dyes

ÎÒÃǶ¼ÔøÔÚ»¯Ñ§¿ÎÉϸù¾ÝpHÊÔÖ½µÄÑÕÉ«ÅжϹýÈÜÒºµÄËá¼î¶È¡£NEB¹«Ë¾µÄÑо¿ÍŶÓÒÔͬÑùµÄÀíÄ»ùÓÚpHÖµµÄÑÕÉ«¸Ä±ä£©Îª»ù´¡£¬¿ª·¢ÁËÒ»ÖÖ¶ÔpHÃô¸ÐµÄ±äɫȾÁÏ£¬¸øDNAÀ©Ôö¸³ÓèÁËÈâÑۿɼûµÄÑÕÉ«¸Ä±ä¡£ÕâÒ»¼¼Êõ¿ÉÒÔ°ïÖúÈËÃÇÖ±½ÓÓÃÑÛ¾¦ÅжϺËËáÀ©ÔöµÄ½á¹û£¬²»ÐèÒª½èÖúÈκÎÌØÊâÉ豸£¬ÔÚÒ°ÍâÑо¿¡¢Ìï¼äÊÔÑé¡¢ÁÙ´²Õï¶ÏµÈÁìÓòÓÐ׏ãÀ«µÄÓ¦ÓÃǰ¾°¡£

2. A single protocol for extraction of gDNA from bacteria and yeast

Ðí¶à·Ö×ÓÉúÎïѧ¼¼Êõ¶¼ÔÚ±»ÈËÃDz»¶ÏÓÅ»¯£¬±ÈÈçPCR¡¢ÖÊÆ×ºÍ²âÐò¡£È»¶ø£¬DNAÌáÈ¡·½·¨È´Ê¼ÖÕûÓÐʲô̫´óµÄ¸Ä±ä¡£

ÕâÏîÑо¿ÎªÈËÃÇչʾÁËÒ»ÖÖеÄDNAÌáÈ¡·½·¨¡£Ñо¿ÏÔʾ£¬¼ÓÈÈÒÒ´¼¼îÐÔÈÜÒº£¬ÄÜÒÔÏàËÆµÄЧÂÊÊͷųöϸ¾úºÍ½ÍĸÖеĵ¥Á´DNA¡£ÀëÐÄËùµÃµÄDNA¿ÉÒÔÖ±½ÓʹÓã¬Ò²¿ÉÒÔÌí¼Óµ½¹è½ºÖù½øÒ»²½´¿»¯¡£ÕâÖÖ¿ìËÙ¡¢¾­¼Ã¶øÇÒ¿É¿¿µÄ·½·¨ÓÐÖúÓÚ¼ø¶¨Î´ÖªµÄ΢ÉúÎËü²»»áºöÊÓ»òÆ«ÏòÌØ¶¨Î¢ÉúÎï¡£ÕâÖÖDNAÌáÈ¡·½·¨ÄÜÔÚ25·ÖÖÓÄÚ´¦Àí¸÷ÖÖÉúÎïÑùÆ·£¬¿ÉÒÔÓÃÓÚÁÙ´²Õï¶Ï»òÕßÉúÎïҽѧÑо¿¡££¨Ïà¹Ø±¨µÀ£ºBioTechniques£º´Óϸ¾úºÍ½ÍĸÖÐÌáÈ¡gDNAµÄ¼ò±ã·½·¨£©

3. Affinity proteomics to study endogenous protein complexes: Pointers, pitfalls, preferences and perspectives

µ°°×³£³£Í¨¹ýÏ໥×÷ÓÃÀ´Ö´ÐÐϸ°û¹¦ÄÜ£¬ÌØÒìÐÔ·ÖÀëµ°°×¼°Æä»¥×÷´îµµ£¬¶ÔÓÚ½âÎöϸ°ûÌåϵºÜÓаïÖú¡£Ç׺Ͳ¶»ñ¼¼ÊõÀûÓøßÇ׺ÍÁ¦¡¢¸ßÌØÒìÐÔµÄÊÔ¼Á£¬ÔÚϸ°ûÌáÈ¡ÎïÖв¶×½Ä¿µÄµ°°×¼°ÆäÏà¹Øµ°°×¡£½«Ç׺Ͳ¶»ñÓëÖÊÆ×½áºÏÆðÀ´½øÐе°°×ÖÊ×é·ÖÎö£¬¿ÉÒÔ·ÖÀëºÍ¼ø¶¨´óÁ¿µÄÄÚÔ´ÐÔµ°°×¸´ºÏÌå¡£ÕâÆªÎÄÕ²ûÊöÁËÇ׺Ͳ¶»ñµ°°×¸´ºÏÌåµÄÓÐЧ²½Ö裬̽ÌÖÁ˽øÐÐÕâÀàʵÑéµÄ×î¼Ñ·½·¨ºÍһЩ³£¼ûÎóÇø¡£

4. CRISPR/Cas9 nuclease cleavage combined with Gibson assembly for seamless cloning

CRISPR-Cas9ÊÇϸ¾úÔÚÂþ³¤µÄ½ø»¯Ê·ÖÐÑÝ»¯³öµÄÖØÒª·ÀÓù»úÖÆ¡£Õâ¸ö¼à¿ØÌåϵÄܹ»¸ù¾ÝÒýµ¼RNAµÄָʾ£¬°Ð±ê²¢½µ½âÈëÇÖÕßµÄÒÅ´«ÎïÖÊ¡£ÏÖÔÚ£¬CRISPR-Cas9ÒѾ­³ÉΪÁËÖËÊÖ¿ÉÈȵĻùÒò×é±à¼­¹¤¾ß£¬°ïÖúÊÀ½ç¸÷µØµÄÑо¿ÕßÃǽâ¾öʵ¼ÊÎÊÌâ¡£

¿Ë¡ÊÇ»ùÒò¹¤³ÌµÄÒ»¸ö»ù±¾¹¤¾ß£¬ÕâÏîÑо¿½«CRISPR¨CCas9ÓëGibson assembly½áºÏÆðÀ´£¬¿ª·¢ÁËÒ»ÖÖ¿ìËÙÓÐЧµÄÎÞ·ì¿Ë¡¼¼Êõ¡£Ñо¿ÈËԱʹÓÃÒ»¸öT7ת¼ģ°åÀ´Éú³ÉÒýµ¼RNA£¨sgRNA£©£¬°Ð±ê¿ËÂ¡ÔØÌåÉϵÄÌØ¶¨Î»µã¡£ËûÃÇÓÃÕâÖÖsgRNAºÍCas9ÇпªÁËÒ»¸ö22 kbµÄÔØÌ壬²¢Í¨¹ýGibson assemblyÔÚÆäÖвåÈëÒ»¶ÎDNA¡£Ñо¿±íÃ÷£¬ÕâÊÇÒ»¸öÄܹ»ÊµÏÖÎÞ·ì¿Ë¡µÄÇ¿´ó¹¤¾ß£¬¿É½«DNAƬ¶ÎÖ±½Ó²åÈëÔØÌåÉϵİÐλµã¡£

5. Preparation of amino acid mixtures for cell-free expression systems

ÕâÆªÎÄÕÂÃèÊöÁËÒ»¸öΪÎÞϸ°ûµ°°×±í´ïÌåÏµÖÆ±¸¸ßŨ¶È°±»ùËá»ìºÏÎïµÄÓÐЧ·½·¨¡£Ñо¿ÈËԱͨ¹ýÕâÒ»·½·¨»ñµÃÁËÀíÏëµÄ°±»ùËá×é³ÉºÍÉúÀíÐÔpH¡£ÕâÖÖ·½·¨Ëٶȿ죬ÈÝÒײÙ×÷£¬Ò²±ÈÉÌÒµ»¯ÊÔ¼ÁºÐ±ãÒË¡£ÈËÃÇ¿ÉÒÔÔÚ´Ë»ù´¡ÉϽøÐиßͨÁ¿ÊµÑé¡¢ÎÞϸ°û´úл¹¤³Ì»òÕß²ôÈë·Ç±ê×¼°±»ùËá¡£

6. Micropatterning strategies to engineer controlled cell and tissue architecture in vitro

΢ͼ°¸»¯¼¼Êõ£¨Micropatterning£©¿ÉÔÚÌåÍâ¿ØÖÆÏ¸°ûºÍ×éÖ¯µÄ¹¹¼Ü£¬ÊÇÄ£Äâ×é֯΢»·¾³µÄʵÓÃÆ½Ì¨¡£ÕâÆª×ÛÊöÎÄÕ½éÉÜÁËһЩ³£ÓõÄ΢ͼ°¸»¯¼¼Êõ£¬¿ÉÒÔÒýµ¼ÐÂÊÖÕÒµ½ÊʺÏ×Ô¼ºµÄ·½·¨£¬°ïÖúËûÃÇ»ñµÃ×Ô¼ºÏëÒªµÄ×é֯ģʽ¡£ÎÄÕ»¹Ì½ÌÖÁË΢ͼ°¸»¯¼¼ÊõĿǰËùÃæÁÙµÄһЩ¹Ø¼üÐÔÌôÕ½¡£

7. Simultaneous isolation of enriched myoblasts and fibroblasts for migration analysis within a novel co-culture assay

ÕâÒ»¼¼Êõ¿ÉÒÔ°ïÖúÈËÃÇÔÚ½ºÔ­Ã¸Ïû»¯Ö®ºó£¬Í¬Ê±·ÖÀëºÍ¸»¼¯³ÉÏËάϸ°ûºÍ³É¼¡Ï¸°û¡£ÕâЩϸ°ûËæºó¿ÉÓÃÓÚÒ»¸ö¹²ÅàÑøµÄ´´ÉËÐÞ¸´ÏµÍ³£¬ÎªÈËÃǽÒʾ³ÉÏËάϸ°û¶Ô³É¼¡Ï¸°ûÇ¨ÒÆµÄÓ°Ïì¡£

8. High-throughput detection of DNA double-strand breaks using image cytometry

ÕâÏîÑо¿ÎªÈËÃÇչʾÁËÒ»¸ö¸ßͨÁ¿µÄ·½·¨£¬ÓÃͼÏñϸ°û·ÖÎö¼¼Êõ£¨image cytometry£©¿Í¹ÛµØÑо¿DNAË«Á´¶ÏÁѵÄϸ°ûÐÞ¸´»úÖÆ¡£

9. Abridged adapter primers increase the target scope of Hi-Plex

Hi-PlexÊÇÒ»ÖÖÒÔÀ©Ôö×ÓΪ»ù´¡µÄ°ÐÏòÐÔ´ó¹æÄ£Æ½ÐвâÐò¼¼Êõ¡£Ñо¿ÈËÔ±¶ÔHi-Plex·½·¨½øÐÐÁ˸ÄÁ¼£¬Ê¹Æä¿ÉÒ԰бê¸ü¶àµÄÀ©Ôö×Ó£¨16¨C1003£©¡£ËûÃÇ»¹Óýض̵ĽÓÍ·ÒýÎïÀ´Ìæ´úÈ«³¤µÄ½ÓÍ·ÒýÎ³É¹¦¼õÉÙÁË֮ǰµÄÍѰÐЧӦ¡£

10. Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection

ÕâÏîÑо¿½«»ùÓÚhybcellµÄ²âÐò¼¼ÊõÓÃÓÚKRASÍ»±ä·ÖÎö£¬²¢½«ÕâÖÖ·½·¨ÓëSanger²âÐò¡¢½¹Á×Ëá²âÐòºÍ¶þ´ú²âÐò½øÐÐÁ˱Ƚϡ£Ñо¿Ö¸³ö£¬ÒÔhybcellΪ»ù´¡µÄ²âÐò¼¼ÊõºÜÊʺÏÔÚÖ×ÁöÑù±¾Öмì²âKRASµãÍ»±ä¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

liu_yanpeng

Ìú¸Ëľ³æ (СÓÐÃûÆø)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÇëÎÊÏà¹ØÎÄÕÂÔÚÄÄ
2Â¥2016-01-29 13:30:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ fuanxitan µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 289 ·Ö105500ҩѧר˶Çóµ÷¼Á(ÕÒBÇøÑ§Ð£) +4 °×ÔÆ123456789 2026-04-13 4/200 2026-04-16 00:18 by ·ÛÇßÈô³¾
[¿¼ÑÐ] ҩѧÇóµ÷¼Á +12 à¶¹þ¼ÓÓÍ 2026-04-14 14/700 2026-04-15 23:49 by ³ÂƤƤ
[¿¼ÑÐ] 291 Çóµ÷¼Á +40 »¯¹¤2026½ì±ÏÒµÉ 2026-04-09 41/2050 2026-04-15 21:54 by noqvsozv
[¿¼ÑÐ] 290µ÷¼ÁÉúÎï0860 +37 ÍÛ¹þ¹þ£¬¡£ 2026-04-11 43/2150 2026-04-15 18:55 by zhuwenxu
[¿¼ÑÐ] ²ÄÁÏ299ר˶Çóµ÷¼Á +17 +21 2026-04-09 17/850 2026-04-15 17:20 by zs92450
[¿¼²©] 26Äêµç³Ø·½Ïò²©Ê¿ÉêÇë 10+3 15615939259 2026-04-09 4/200 2026-04-15 14:22 by kwansei
[¿¼ÑÐ] 367Çóµ÷¼Á +11 hffQAQ 2026-04-09 11/550 2026-04-14 17:48 by lhj2009
[¿¼ÑÐ] ²ÄÁÏרҵ344Çóµ÷¼Á +17 hualkop 2026-04-10 22/1100 2026-04-14 16:21 by sxdj2
[¿¼ÑÐ] 305Çóµ÷¼Á +8 Â꿨°Í¿¨boom 2026-04-11 8/400 2026-04-14 09:04 by pengliang8036
[¿¼ÑÐ] »úе»¹Óл¹ÓÐÃû¶îÂð£¿Ì«ÄÑÁË +8 ЦЦԬ 2026-04-10 8/400 2026-04-14 08:44 by screening
[¿¼ÑÐ] Çóµ÷¼Á288 +7 ioodiiij 2026-04-10 9/450 2026-04-13 08:33 by Hayaay
[¿¼ÑÐ] 2±¾£¬³õÊÔ303£¬0860Çóµ÷¼Á +6 floriea 2026-04-12 8/400 2026-04-12 18:13 by zhouxiaoyu
[¿¼ÑÐ] 296Çóµ÷¼Á +14 Íô£¡£¿£¡ 2026-04-10 16/800 2026-04-12 10:48 by zhouyuwinner
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũ΢ÉúÎ288·Ö£¬ÈýÄêʵÑé¾­Àú +11 ´úfish 2026-04-09 11/550 2026-04-12 10:21 by Hayaay
[¿¼ÑÐ] ũѧ0904 312Çóµ÷¼Á +6 Say Never 2026-04-10 6/300 2026-04-11 10:33 by wwj2530616
[¿¼ÑÐ] 087100³õÊÔ311Çóµ÷¼Á +4 ÈÎÑÅÇÙ 2026-04-09 4/200 2026-04-11 10:33 by zhq0425
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤µ÷¼Á +12 ·ñ¼«Ì©À´2026 2026-04-10 13/650 2026-04-11 00:28 by wangjihu
[¿¼ÑÐ] 263ÄÜÔ´¶¯Á¦×¨Ë¶Çóµ÷¼Á +4 ¼Ó´óºÅ·¹ºÐ´ü 2026-04-10 4/200 2026-04-10 20:52 by gong120082
[¿¼ÑÐ] ±¾¿Æ211 ¹¤¿Æ085400 280·ÖÇóµ÷¼Á ¿É¿çרҵ +3 LZH£¨µÈ´ýµ÷¼ÁÖÐ 2026-04-09 3/150 2026-04-09 21:29 by wutongshun
[¿¼ÑÐ] 083200 ³õÊÔ305·Ö Çóµ÷¼Á Ôݲ»¿¼ÂÇ¿çרҵ +15 Claireyyyy 2026-04-09 15/750 2026-04-09 16:11 by zhuimr
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û